- Home
- GPCR vs JAMF Comparison
GPCR vs JAMF Comparison
Compare GPCR & JAMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- JAMF
- Stock Information
- Founded
- GPCR 2016
- JAMF 2002
- Country
- GPCR United States
- JAMF United States
- Employees
- GPCR N/A
- JAMF N/A
- Industry
- GPCR
- JAMF Computer Software: Prepackaged Software
- Sector
- GPCR
- JAMF Technology
- Exchange
- GPCR Nasdaq
- JAMF Nasdaq
- Market Cap
- GPCR 1.8B
- JAMF 1.9B
- IPO Year
- GPCR 2023
- JAMF 2020
- Fundamental
- Price
- GPCR $27.03
- JAMF $15.18
- Analyst Decision
- GPCR Buy
- JAMF Buy
- Analyst Count
- GPCR 6
- JAMF 7
- Target Price
- GPCR $85.67
- JAMF $23.00
- AVG Volume (30 Days)
- GPCR 797.2K
- JAMF 644.7K
- Earning Date
- GPCR 11-13-2024
- JAMF 11-07-2024
- Dividend Yield
- GPCR N/A
- JAMF N/A
- EPS Growth
- GPCR N/A
- JAMF N/A
- EPS
- GPCR N/A
- JAMF N/A
- Revenue
- GPCR N/A
- JAMF $615,070,000.00
- Revenue This Year
- GPCR N/A
- JAMF $14.06
- Revenue Next Year
- GPCR N/A
- JAMF $13.13
- P/E Ratio
- GPCR N/A
- JAMF N/A
- Revenue Growth
- GPCR N/A
- JAMF 13.85
- 52 Week Low
- GPCR $29.48
- JAMF $14.02
- 52 Week High
- GPCR $62.74
- JAMF $21.41
- Technical
- Relative Strength Index (RSI)
- GPCR 35.94
- JAMF 46.42
- Support Level
- GPCR $30.81
- JAMF $14.73
- Resistance Level
- GPCR $36.42
- JAMF $15.35
- Average True Range (ATR)
- GPCR 2.10
- JAMF 0.47
- MACD
- GPCR -0.15
- JAMF 0.05
- Stochastic Oscillator
- GPCR 25.07
- JAMF 36.90
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578.
About JAMF Jamf Holding Corp.
Jamf Holding Corp is the standard in Apple Enterprise Management, and its cloud software platform is the vertically focused Apple infrastructure and security platform. The company helps organizations, including businesses, hospitals, schools, and government agencies, connect, manage, and protect Apple products, apps, and corporate resources in the cloud without ever having to touch the devices. It sells its Software-as-a-Service, or SaaS, solutions via a subscription model, through a direct sales force, online, and indirectly via its channel partners, including Apple. The company operates in The Americas; Europe, the Middle East, India, and Africa; and Asia Pacific.